Inhibition of apoptosis by expression of antiapoptotic proteins in recombinant human keratinocytes

Cell Transplantation

Volumn 16, Issue 6, 2007, Pages 663-674

  Choi, Claudia Y U ^a   Reimers, Kerstin ^a   Allmeling, Christina ^a   Kall, Susanne ^a   Choi, Yeong Hoon ^b   Vogt, Peter M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Allotransplantation; Apoptosis; Inhibition of rejection; Keratinocytes

Indexed keywords

CASPASE 8; FAS LIGAND; FLICE INHIBITORY PROTEIN; PROTEIN FAIM; PROTEIN INHIBITOR; PROTEIN LFG; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CD8 ANTIGEN; FAIM PROTEIN, HUMAN; FAIM2 PROTEIN, HUMAN; FAS ANTIGEN; MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; CELL SURVIVAL; COCULTURE; DRUG EFFECT; FEASIBILITY STUDY; GENE EXPRESSION; GRAFT REJECTION; IMMUNOLOGY; METABOLISM;

ANTIGENS, CD8; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; FAS LIGAND PROTEIN; FEASIBILITY STUDIES; GENE EXPRESSION; GRAFT REJECTION; HUMANS; KERATINOCYTES; MEMBRANE PROTEINS; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 38449105613     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000007783465037     Document Type: Article

References (42)

1. Abe, K.; Kurakin, A.; Mohseni-Maybodi, M.; Kay, B.; Khosravi-Far, R. The complexity of TNF-related apoptosis-inducing ligand. Ann. NY Acad. Sci. 926:52-63; 2000.
2. Achauer, B. M.; Hewitt, C. W.; Black, K. S.; Martinez, S. E.; Waxman, K. S.; Ott, R. A.; Furnas, D. W. Long-term skin allograft survival after short-term cyclosporin treatment in a patient with massive burns. Lancet 1:14-15; 1986.
3. Andreassi, L. History of keratinocyte cultivation. Burns 18(Suppl. 1):S2-S4; 1992.
4. Barclay, A. N.; Mason, D. W. Induction of 1a antigen in rat epidermal cells and gut epithelium by immunological stimuli. J. Exp. Med. 156:1665-1676; 1982.
5. Bettger, W. J.; Boyce, S. T.; Walthall, B. J.; Ham, R. G. Rapid clonal growth and serial passage of human diploid fibroblasts in a lipid-enriched synthetic medium supplemented with epidermal growth factor, insulin, and dexamethasone. Proc. Natl. Acad. Sci. USA 78:5588-5592; 1981.
6. Boyce, S. T.; Christianson, D. J.; Hansbrough, J. F. Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J. Biomed. Mater. Res. 22:939-957; 1988.
7. Boyce, S. T.; Hansbrough, J. F. Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery 103:421-431; 1988.
8. Cao, T.; Wang, X. J.; Roop, D. R. Regulated cutaneous gene delivery: The skin as a bioreactor. Hum. Gene Ther. 11:2297-2300; 2000.
9. Chang, D. W.; Xing, Z.; Pan, Y.; Algeciras-Schimnich, A.; Barnhart, B. C.; Yaish-Ohad, S.; Peter, M. E.; Yang, X. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21: 3704-3714; 2002.
10. Del Rio, M.; Gache, Y.; Jorcano, J. L.; Meneguzzi, G.; Larcher, F. Current approaches and perspectives in human keratinocyte-based gene therapies. Gene Ther. 11(Suppl. 1):S57-S63; 2004.
11. De Perrot, M.; Sekine, Y.; Fischer, S.; Waddell, T. K.; McRae, K.; Liu, M.; Wigle, D. A.; Keshavjee, S. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am. J. Respir. Crit. Care Med. 165:211-215; 2002.
12. Djerbi, M.; Screpanti, V.; Catrina, A. I.; Bogen, B.; Biberfeld, P.; Grandien, A. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 190:1025-1032; 1999.
13. French, L. E.; Tschopp, J. Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors. J. Exp. Med. 190:891-894; 1999.
14. Gallico, III, G. G.; O'Connor, N. E.; Compton, C. C.; Kehinde, O.; Green, H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N. Engl. J. Med. 311:448-451; 1984.
15. Halamay, K. E.; Kirkman, R. L.; Sun, L.; Yamada, A.; Fragoso, R. C.; Shimizu, K.; Mitchell, R. N.; McKay, D. B. CD8 T cells are sufficient to mediate allorecognition and allograft rejection. Cell Immunol. 216:6-14; 2002.
16. Herndon, D. N.; Barrow, R. E.; Rutan, R. L.; Rutan, T. C.; Desai, M. H.; Abston, S. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann. Surg. 209:547-552; 1989.
17. Itoh, N.; Yonehara, S.; Ishii, A.; Yonehara. M.; Mizushima, S.; Sameshima, M.; Hase, A.; Seto, Y.; Nagata, S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243; 1991.
18. Kagi, D.; Vignaux, F.; Ledermann, B.; Burki, K.; Depraetere, V.; Nagata, S.; Hengartner, H.; Golstein, P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530; 1994.
19. Kim, H.; Whartenby, K. A.; Georgantas, III, R. W.; Wingard, J.; Civin, C. I. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis. Stem Cells 20:174-182; 2002.
20. Krasinskas, A. M.; Eiref, S. D.; McLean, A. D.; Kreisel, D.; Gelman, A. E.; Popma, S. H.; Moore, J. S.; Rosengard, B. R. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection. Transplantation 70:514-521; 2000.
21. Kreis, R. W.; Mackie, D. P.; Vloemans, A. W.; Hermans, R. P.; Hoekstra, M. J. Widely expanded postage stamp skin grafts using a modified Meek technique in combination with an allograft overlay. Burns 19:142-145; 1993.
22. Kuroyanagi, Y.; Kenmochi, M.; Ishihara, S.; Takeda, A.; Shiraishi, A.; Ootake, N.; Uchinuma, E.; Torikai, K.; Shioya, N. A cultured skin substitute composed of fibroblasts and keratinocytes with a collagen matrix: preliminary results of clinical trials. Ann. Plast. Surg. 31:340-349; 1993.
23. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685; 1970.
24. Lam, P. K.; Chan, E. S.; Liew, C. T.; Lau, C. H.; Yen, S. C.; King, W. W. The efficacy of collagen dermis membrane and fibrin on cultured epidermal graft using an athymic mouse model. Ann. Plast. Surg. 43:523-528; 1999.
25. Leverkus, M.; Neumann, M.; Mengling, T.; Rauch, C. T.; Brocker, E. B.; Krammer, P. H.; Walczak, H. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res. 60:553-559; 2000.
26. Lowin, B.; Hahne, M.; Mattmann, C.; Tschopp, J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-652; 1994.
27. Nagata, S. Apoptosis by death factor. Cell 88:355-365; 1997.
28. Nor, J. E.; Christensen, J.; Mooney, D. J.; Polverini, P. J. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am. J. Pathol. 154:375-384; 1999.
29. Rothstein, T. L.; Zhong, X.; Schram, B. R.; Negm, R. S.; Donohoe, T. J.; Cabrai, D. S.; Foote, L. C.; Schneider, T. J. Receptor-specific regulation of B-cell susceptibility to Fas-mediated apoptosis and a novel Fas apoptosis inhibitory molecule. Immunol. Rev. 176:116-133; 2000.
30. Salvesen, G. S.; Dixit, V. M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA 96: 10964-10967; 1999.
31. Schneider, T. J.; Fischer, G. M.; Donohoe, T. J.; Colarusso, T. P.; Rothstein, T. L. A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J. Exp. Med. 189: 949-956; 1999.
32. Schweitzer, B.; Taylor, V.; Welcher, A. A.; McClelland, M.; Suter, U. Neural membrane protein 35 (NMP35): A novel member of a gene family which is highly expressed in the adult nervous system. Mol. Cell. Neurosci. 11:260-273; 1998.
33. Sole, C.; Dolcet, X.; Segura, M. F.; Gutierrez, H.; Diaz-Meco, M. T.; Gozzelino, R.; Sanchis, D.; Bayascas, J. R.; Gallego, C.; Moscat, J.; Davies, A. M.; Comella, J. X. The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-kapp B signaling. J. Cell Biol. 167:479-492; 2004.
34. Somia, N. V.; Schmitt, M. J.; Vetter, D. E.; Van Antwerp, D.; Heinemann. S. F.; Verma, I. M. LFG: An anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc. Natl. Acad. Sci. USA 96:12667-12672; 1999.
35. Stanciu, L. A.; Shute, J.; Holgate, S. T.; Djukanovic, R. Production of IL-8 and IL-4 by positively and negatively selected CD4+ and CD8+ human T cells following a four-step cell separation method including magnetic cell sorting (MACS). J. Immunol. Methods 189:107-115; 1996.
36. Suda, T.; Nagata, S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179: 873-879; 1994.
37. Suda, T.; Okazaki, T.; Naito, Y.; Yokota, T.; Arai, N.; Ozaki, S.; Nakao, K.; Nagata, S. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806-3813; 1995.
38. Vogt, P. M.; Thompson, S.; Andree, C.; Liu, P.; Breuing, K.; Hatzis, D.; Brown, H.; Mulligan, R. C.; Eriksson, E. Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc. Natl. Acad. Sci. USA 91:9307-9311; 1994.
39. Wallach, D.; Kovalenko, A. V.; Varfolomeev, E. E.; Boldin, M. P. Death-inducing functions of ligands of the tumor necrosis factor family: A Sanhedrin verdict. Curr. Opin. Immunol. 10:279-288; 1998.
40. Wang, J.; Lobito, A. A.; Shen, F.; Hornung, F.; Winoto, A.; Lenardo, M. J. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur. J Immunol. 30:155-163; 2000.
41. Yeh, W. C.; Itie, A.; Elia, A. J.; Ng, M.; Shu, H. B.; Wakeham, A.; Mirtsos, C.; Suzuki, N.; Bonnard, M.; Goeddel, D. V.; Mak, T. W. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12:633-642; 2000.
42. Zhong, X.; Schneider, T. J.; Cabrai, D. S.; Donohoe, T. J.; Rothstein, T. L. An alternatively spliced long form of Fas apoptosis inhibitory molecule (FAIM) with tissue-specific expression in the brain. Mol. Immunol. 38:65-72; 2001.